Member-supported news for Southern California
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Support for KPCC comes from:

COVID-19 AMA: J&J Latest, Vaccine Demand And More

A staff member checks a COVID-19 vaccine package in Beijing. China has approved Sinopharm's vaccine, after clinical trials showed the drug has a 79.34% efficacy against COVID-19.

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with UCI Dr. Shruti Gohil.

In our continuing series looking at the latest medical research and news on COVID-19, Larry Mantle speaks with UCI Dr. Shruti Gohil. 

Topics today include:

  • We know even more about the effectiveness of vaccines 

  • The FDA and CDC expected to advise on J&J vaccine today 

  • For some states, vaccine demand is actually down

  • UC and Cal State campuses will requirestudents to be vaccinated in the fall 

Guest:

Shruti Gohil, M.D., professor of medicine and associate medical director for epidemiology and infection prevention at UC Irvine’s School of Medicine

Stay Connected